Výsledky vyhľadávania - "Randomized Controlled Trials as Topic/methods [MeSH]"
-
1
Autori: a ďalší
Zdroj: Respir Res
Respiratory Research, Vol 25, Iss 1, Pp 1-17 (2024)Predmety: RC705-779, Chronic obstructive pulmonary disease, Network Meta-Analysis, Review, Bayesian, Diseases of the respiratory system, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, GRADE, Treatment Outcome, 0302 clinical medicine, Meta-Analysis as Topic, Head-to-head comparison, Humans, Bucher ITC, Humans [MeSH], Treatment Outcome [MeSH], Single-inhaler triple therapy, Randomized Controlled Trials as Topic/methods [MeSH], Network Meta-Analysis as Topic [MeSH], Pulmonary Disease, Chronic Obstructive/drug therapy [MeSH], Pulmonary Disease, Chronic Obstructive/therapy [MeSH], Randomized controlled trials, Network meta-analysis, Pulmonary Disease, Chronic Obstructive/diagnosis [MeSH], Frequentist, Indirect treatment comparison, Randomized Controlled Trials as Topic
-
2
Autori: a ďalší
Zdroj: BMC Anesthesiol
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-14 (2024)Predmety: Adult, General anesthesia, Pharyngitis, Anesthesia, General, Endotracheal tube, Systematic review and metanalysis, Postoperative Complications, Anesthesiology, Systematic Review, Intubation, Intratracheal/methods [MeSH], Pharyngitis/etiology [MeSH], Adult [MeSH], Humans [MeSH], Anesthesia, General/methods [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Preoperative Care/methods [MeSH], Ketamine/therapeutic use [MeSH], Ketamine/administration, Postoperative Complications/prevention, Postoperative sore throat, Pharyngitis/prevention, Ketamine gargle, Preoperative Care, Intubation, Intratracheal, Humans, RD78.3-87.3, Ketamine, Randomized Controlled Trials as Topic
-
3
Autori: a ďalší
Zdroj: Crit Care
Predmety: Esmolol, Research, Adrenergic beta-Antagonists, Landiolol, Propanolamines, 03 medical and health sciences, Betablocker, 0302 clinical medicine, Humans [MeSH], Propanolamines/therapeutic use [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Sepsis/mortality [MeSH], Septic shock, Mortality, Sepsis/drug therapy [MeSH], Urea/analogs, Randomized Controlled Trials as Topic/statistics, Sepsis, Adrenergic beta-Antagonists/therapeutic use [MeSH], Humans, Urea, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39605034
https://repository.publisso.de/resource/frl:6518310 -
4
Autori: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-12 (2024)Predmety: Medicine (General), Reporting quality, Research, Survival analysis, Time-to-event outcomes, Meta-analysis, Epidemiologic Studies, 03 medical and health sciences, R5-920, 0302 clinical medicine, Meta-Analysis as Topic, Research Design, Outcome Assessment, Health Care, Systematic review, Humans, Quantitative analysis, Research Design/standards [MeSH], Randomized Controlled Trials as Topic/standards [MeSH], Humans [MeSH], Outcome Assessment, Health Care/statistics, Epidemiologic Studies [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Outcome Assessment, Health Care/standards [MeSH], Outcome Assessment, Health Care/methods [MeSH], Randomized Controlled Trials as Topic/statistics, Meta-Analysis as Topic [MeSH], Research Design/statistics, Systematic Reviews as Topic/methods [MeSH], Systematic Reviews as Topic, Randomized Controlled Trials as Topic
-
5
Autori: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-22 (2024)Predmety: Medicine (General), Interactive response technology (IRT), Random Allocation [MeSH], Multi-center clinical trial, Research, Humans [MeSH], Patient Selection [MeSH], Drug supply chain management, Randomized Controlled Trials as Topic/methods [MeSH], Research Design [MeSH], Poisson-gamma model, Patient Selection, Klinisk medicin, Random Allocation, R5-920, Research Design, Humans, Clinical Medicine, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
-
6
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-14 (2024)
BMC medical research methodology 24(1), 223 (2024). doi:10.1186/s12874-024-02335-xPredmety: Medicine (General), Šidák, Endpoint Determination, Type I error rate, All-or-none approach, Randomization, Allocation bias, R5-920, Bias, Humans, Multiple testing, Computer Simulation, Family-wise error rate, Randomized Controlled Trials as Topic, Clinical Trials as Topic, Multiple endpoints, Models, Statistical, Research, Intersection-union test, Research Design, Sample Size, Co-primary endpoints, Endpoint Determination/methods [MeSH], Algorithms [MeSH], Bias [MeSH], Humans [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Computer Simulation [MeSH], Research Design [MeSH], Endpoint Determination/statistics, Sample Size [MeSH], Clinical Trials as Topic/statistics, Clinical Trials as Topic/methods [MeSH], Models, Statistical [MeSH], Randomized Controlled Trials as Topic/statistics, Algorithms, SidakAll-or-none approach
Popis súboru: application/pdf
-
7
Autori:
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-16 (2024)
BMC medical research methodology 24, 197 (2024). doi:10.1186/s12874-024-02306-2Predmety: Medicine (General), Sample size, Research, Historically Controlled Study, Control Groups, Historical control, R5-920, Type I error probability, Research Design, Power, Sample Size, Humans, Randomized clinical trial, External controls, Control Groups [MeSH], Humans [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Historically Controlled Study [MeSH], Research Design [MeSH], Sample Size [MeSH], Equivalence, Randomized Controlled Trials as Topic/statistics, Randomized Controlled Trials as Topic
-
8
Autori:
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-16 (2024)
Hamza, Tasnim; Schwarzer, Guido; Salanti, Georgia (2024). crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression. BMC Medical research methodology, 24(169) BioMed Central 10.1186/s12874-023-02130-0 <http://dx.doi.org/10.1186/s12874-023-02130-0>
Hamza, Tasnim; Schwarzer, Guido; Salanti, Georgia (2024). crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression. BMC Medical research methodology, 24(1), p. 169. BioMed Central 10.1186/s12874-023-02130-0 <http://dx.doi.org/10.1186/s12874-023-02130-0>Predmety: Real-world evidence, Medicine (General), R package, Network Meta-Analysis, 610 Medicine & health, Network meta-regression, Bayes Theorem, 16. Peace & justice, Risk of bias, Algorithms [MeSH], Humans [MeSH], Software [MeSH], Software, Randomized Controlled Trials as Topic/methods [MeSH], Bayes Theorem [MeSH], Research Design [MeSH], Network Meta-Analysis as Topic [MeSH], Network meta-analysis, Observational studies, Randomized Controlled Trials as Topic/statistics, R5-920, Meta-Analysis as Topic, Network meta-analysis Network meta-regression Observational studies R package Real-world evidence Risk of bias, 360 Social problems & social services, Research Design, Humans, Algorithms, Randomized Controlled Trials as Topic
Popis súboru: application/pdf; pdf
-
9
Autori: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-9 (2024)Predmety: Male, Medicine (General), Disability-free longevity, Risk Assessment, 01 natural sciences, Aged [MeSH], United States [MeSH], Outcome Assessment, Health Care/statistics, Randomized Controlled Trials as Topic/methods [MeSH], Aspirin, Risk Assessment/statistics, Data science methodologies, Proportional Hazards Models [MeSH], Decision Trees [MeSH], Male [MeSH], Models, Statistical [MeSH], Randomized Controlled Trials as Topic/statistics, Machine Learning [MeSH], Outcome risk modelling, Risk Assessment/methods [MeSH], Female [MeSH], Humans [MeSH], Random forest, Treatment Outcome [MeSH], Heterogeneity of treatment effect, Outcome Assessment, Health Care/methods [MeSH], Research, Clinical trial, Aspirin/therapeutic use [MeSH], Decision tree, Machine Learning, 03 medical and health sciences, R5-920, 0302 clinical medicine, Outcome Assessment, Health Care, Humans, 0101 mathematics, Aged, Proportional Hazards Models, Randomized Controlled Trials as Topic, Models, Statistical, Decision Trees, 16. Peace & justice, United States, 3. Good health, Treatment Outcome, Female
-
10
Autori: a ďalší
Zdroj: BMC Geriatr
BMC Geriatrics, Vol 24, Iss 1, Pp 1-41 (2024)Predmety: SDG-03: Good health and well-being, Schrittzähler, Schlaganfall, Health Promotion, Walking, Community-dwelling older adults, Wearable Electronic Devices, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Stroke prevention, Modifiable risk factors, Humans, ddc:610, Pedometer-based walking, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, RC952-954.6, Middle Aged, 16. Peace & justice, Actigraphy, Hohes Alter, Älterer Mensch, 3. Good health, Modifable risk factors, Stroke, 610 Medizin, Gesundheit, Geriatrics, Systematic Review, Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Wearable Electronic Devices [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Stroke/prevention, Walking/physiology [MeSH], Independent Living [MeSH], Stroke/epidemiology [MeSH], Actigraphy/instrumentation [MeSH], Actigraphy/methods [MeSH], Health Promotion/methods [MeSH], Alter, Independent Living, Randomized controlled trial (RCT), Risikofaktor
Popis súboru: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
-
11
Autori: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-22 (2024)Predmety: Medicine (General), Lung Neoplasms, Pyridines, 01 natural sciences, IPCW, 03 medical and health sciences, R5-920, Organophosphorus Compounds, 0302 clinical medicine, Crizotinib, Parametric g-formula, Humans, Treatment switching, 0101 mathematics, Proportional Hazards Models, Randomized Controlled Trials as Topic, Models, Statistical, Treatment-confounder feedback, Research, Survival analysis, Intention to Treat Analysis, 3. Good health, Time-dependent confounding, Pyrimidines, Treatment Outcome, Clinical Trials, Phase III as Topic, Pyrazoles, Crizotinib/therapeutic use [MeSH], Intention to Treat Analysis/methods [MeSH], Clinical Trials, Phase III as Topic/methods [MeSH], Pyridines/therapeutic use [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Pyrazoles/therapeutic use [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Proportional Hazards Models [MeSH], Pyrimidines/therapeutic use [MeSH], Clinical Trials, Phase III as Topic/statistics, Models, Statistical [MeSH], Randomized Controlled Trials as Topic/statistics, Lung Neoplasms/drug therapy [MeSH], Organophosphorus Compounds/therapeutic use [MeSH]
-
12
Autori: a ďalší
Zdroj: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-17 (2024)
Riberholt, C G, Olsen, M H, Milan, J B, Hafliðadóttir, S H, Svanholm, J H, Pedersen, E B, Lew, C C H, Asante, M A, Pereira Ribeiro, J, Wagner, V, Kumburegama, B W M B, Lee, Z-Y, Schaug, J P, Madsen, C & Gluud, C 2024, 'Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses-the METSA systematic review', BMC Medical Research Methodology, vol. 24, no. 1, 196. https://doi.org/10.1186/s12874-024-02318-y
Riberholt, C G, Olsen, M H, Milan, J B, Hafliðadóttir, S H, Svanholm, J H, Pedersen, E B, Lew, C C H, Asante, M A, Pereira Ribeiro, J, Wagner, V, Kumburegama, B W M B, Lee, Z Y, Schaug, J P, Madsen, C & Gluud, C 2024, ' Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses – the METSA systematic review ', BMC Medical Research Methodology, vol. 24, 196 . https://doi.org/10.1186/s12874-024-02318-yPredmety: Research-on-research, Trial sequential analysis, Medicine (General), Research, Methodology, 3. Good health, Meta-analysis, Research Design/standards [MeSH], Randomized Controlled Trials as Topic/standards [MeSH], Humans [MeSH], Systematic review, Randomized Controlled Trials as Topic/methods [MeSH], Randomized Controlled Trials as Topic/statistics, Meta-Analysis as Topic [MeSH], Systematic Reviews as Topic/methods [MeSH], R5-920, Randomized Controlled Trials as Topic/methods, Meta-Analysis as Topic, Research Design, Humans, Systematic Reviews as Topic/methods, Research Design/standards, Systematic Reviews as Topic, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39251912
https://doaj.org/article/d15878bf69dc442d9297c03a4066960a
https://vbn.aau.dk/ws/files/744329742/Riberholt_et_al._2024_._Major_mistakes_or_errors_in_the_use_of_trial_sequential_analysis_in_systematic_reviews_or_meta-analyses_-_the_METSA_systematic_review.pdf
https://doi.org/10.1186/s12874-024-02318-y
https://vbn.aau.dk/da/publications/a8a89495-74c1-4bcf-88d5-a05d8e738dd5
http://www.scopus.com/inward/record.url?scp=85203393011&partnerID=8YFLogxK
https://curis.ku.dk/ws/files/412389337/s12874_024_02318_y.pdf
https://repository.publisso.de/resource/frl:6492893 -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Eur Arch Psychiatry Clin Neurosci
Predmety: Adult, Male, Adolescent [MeSH], Female [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Randomized clinical trial, Randomized Controlled Trials as Topic/methods [MeSH], Middle Aged [MeSH], Schizophrenia, Endurance Training [MeSH], Research Design [MeSH], Exercise, Male [MeSH], Data Interpretation, Statistical [MeSH], Original Paper, Physical activity, Young Adult [MeSH], Psychiatric Rehabilitation [MeSH], Single-Blind Method [MeSH], Recovery, Outcome Assessment, Health Care [MeSH], Schizophrenia/rehabilitation [MeSH], Cognition, ddc:610, Adolescent, Middle Aged, Psychiatric Rehabilitation, 3. Good health, Young Adult, Endurance Training, 03 medical and health sciences, 0302 clinical medicine, Research Design, Data Interpretation, Statistical, Outcome Assessment, Health Care, Humans, Multicenter Studies as Topic, Female, Single-Blind Method, Aged, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/32748261
https://link.springer.com/article/10.1007/s00406-020-01175-2
https://europepmc.org/article/MED/32748261
https://www.scilit.net/article/f77493653726dcd063fb3b90aed52de3
https://link.springer.com/content/pdf/10.1007/s00406-020-01175-2.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257533
https://pubmed.ncbi.nlm.nih.gov/32748261/
https://resolver.sub.uni-goettingen.de/purl?gro-2/81411
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/79138
https://doi.org/10.1007/s00406-020-01175-2
https://opus.bibliothek.uni-augsburg.de/opus4/files/79138/79138.pdf
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-791385
https://repository.publisso.de/resource/frl:6469542 -
14
Autori: a ďalší
Zdroj: Adm Policy Ment Health
Predmety: Mental Health Services, Formative Feedback, Mental Disorders, 05 social sciences, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Artificial Intelligence, Commentary, Humans, 0501 psychology and cognitive sciences, Randomized Controlled Trials as Topic/standards [MeSH], Health Services Research/standards [MeSH], Humans [MeSH], Artificial intelligence, Precision Medicine/methods [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Artificial Intelligence [MeSH], Treatment navigation, Health Services Research/organization, Mental Health Services/organization, Routine outcome monitoring, Mental Disorders/therapy [MeSH], Formative Feedback [MeSH], Personalized and precision mental health, Health Services Research, Precision Medicine, Randomized Controlled Trials as Topic
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/32715429
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316220
https://www.ncbi.nlm.nih.gov/pubmed/32715429
https://link.springer.com/article/10.1007/s10488-020-01053-y
https://pubmed.ncbi.nlm.nih.gov/32715429/
https://repository.publisso.de/resource/frl:6468250 -
15
Autori: a ďalší
Zdroj: Neurotherapeutics
Predmety: Multiple Sclerosis, Drug Substitution, Natalizumab, Leukoencephalopathy, Progressive Multifocal, Observational Studies as Topic, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Risk Factors, Neurology, Immunologic Factors/administration, Leukoencephalopathy, Progressive Multifocal/immunology [MeSH], Leukoencephalopathy, Progressive Multifocal/prevention, Drug Substitution/methods [MeSH], Humans [MeSH], Multiple Sclerosis/drug therapy [MeSH], Treatment Outcome [MeSH], Natalizumab/adverse effects [MeSH], Randomized Controlled Trials as Topic/methods [MeSH], Neurosurgery, Risk Factors [MeSH], Neurobiology, Commentary, Multiple Sclerosis/immunology [MeSH], Natalizumab/administration, Observational Studies as Topic/methods [MeSH], Leukoencephalopathy, Progressive Multifocal/chemically induced [MeSH], Neurosciences, Humans, Immunologic Factors, Randomized Controlled Trials as Topic
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s13311-021-01102-w.pdf
https://pubmed.ncbi.nlm.nih.gov/34480292
https://link.springer.com/article/10.1007/s13311-021-01148-w
https://paperity.org/p/271531199/multiple-sclerosis-switching-from-natalizumab-to-other-high-efficacy-treatments-to
https://europepmc.org/article/MED/34729691
https://www.ncbi.nlm.nih.gov/pubmed/34480292
https://pubmed.ncbi.nlm.nih.gov/34729691/
https://link.springer.com/content/pdf/10.1007/s13311-021-01102-w.pdf
https://repository.publisso.de/resource/frl:6444132
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science